Given the well-established link between immune function and the development and progression of tumors, especially in the context of anti-tumor immunity, this study aims to investigate the expression and clinical prognosis of NFIL3 and its correlation with the immune microenvironment across a spectrum of cancer types. This evidence concerns the gene NFIL3 and cancer.